白细胞介素9变化与非裔美国人阿尔茨海默病的关联
研究在具有AD家族史的中年健康队列(n=68)和老年认知正常、轻度认知障碍或AD痴呆队列(n=125)中检测脑脊液细胞因子,发现认知正常的非裔美国人较白人脑脊液tau、p-Tau181和IL-9水平更低,且AD仅与非裔美国人脑脊液IL-9升高相关。免疫组化和死后基因表达分析进一步显示AD与IL-9上调的分子改变仅在非裔美国人中相关,提示AD分子表型因族裔而异。
要点
- 认知正常的非裔美国人较白人脑脊液tau、p-Tau181和IL-9水平更低。
- AD仅与非裔美国人脑脊液IL-9升高相关,白人无此关联。
- AD与IL-9上调分子改变的相关性仅在非裔美国人中观察到。
核心结论
- 非裔美国人与白人之间基线和AD相关的IL-9差异提示AD分子表型因祖先背景而异。
研究设计与样本
- 在具有AD家族史的中年健康队列(n=68)和老年认知正常、轻度认知障碍或AD痴呆队列(n=125)中进行多重细胞因子分析。
- 对非裔美国人和白人脑组织(n=38)进行IL-9相关蛋白免疫组化分析。
- 分析公开的Mount Sinai队列(26名非裔美国人和180名白人)死后IL-9相关基因表达谱。
主要发现
- 与认知正常白人相比,认知正常非裔美国人在两个活体队列中脑脊液tau、p-Tau181和IL-9水平更低。
- AD仅与非裔美国人脑脊液IL-9水平升高相关,与白人无关。
- 免疫组化显示血管周围、神经元和胶质细胞对IL-9有免疫反应性。
- 独立美国队列定量分析显示AD与IL-9上调的分子改变(上游分化标志物和下游效应细胞标志物)仅在非裔美国人中相关。
临床怎么用
- 未来涉及独特人群的AD研究需考虑遗传和非遗传因素。
- IL-9相关标志物在AD中的解释应考虑族裔背景差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Compared to older Caucasians, older African Americans have higher risks of developing Alzheimer disease (AD) and lower cerebrospinal fluid (CSF) tau biomarker levels. It is not known whether tau-related differences begin earlier in life or whether race modifies other AD-related biomarkers such as inflammatory proteins. METHODS: We performed multiplex cytokine analysis in a healthy middle-aged cohort with family history of AD (n = 68) and an older cohort (n = 125) with normal cognition (NC), mild cognitive impairment, or AD dementia. After determining baseline interleukin (IL)-9 level and AD-associated IL-9 change to differ according to race, we performed immunohistochemical analysis for proteins mechanistically linked to IL-9 in brains of African Americans and Caucasians (n = 38), and analyzed postmortem IL-9-related gene expression profiles in the publicly available Mount Sinai cohort (26 African Americans and 180 Caucasians). RESULTS: Compared to Caucasians with NC, African Americans with NC had lower CSF tau, p-Tau181 , and IL-9 levels in both living cohorts. Conversely, AD was only correlated with increased CSF IL-9 levels in African Americans but not Caucasians. Immunohistochemical analysis revealed perivascular, neuronal, and glial cells immunoreactive to IL-9, and quantitative analysis in independent US cohorts showed AD to correlate with molecular changes (upstream differentiation marker and downstream effector cell marker) of IL-9 upregulation only in African Americans but not Caucasians. INTERPRETATION: Baseline and AD-associated IL-9 differences between African Americans and Caucasians point to distinct molecular phenotypes for AD according to ancestry. Genetic and nongenetic factors need to be considered in future AD research involving unique populations. ANN NEUROL 2019;86:407-418.
引用
- Wharton W, Kollhoff AL, Gangishetti U, et al. Interleukin 9 alterations linked to alzheimer disease in african americans. Ann Neurol. 2019. PMID: 31271450. doi:10.1002/ana.25543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。